COBRA1 Antibody [K14G15]

Catalog No.: F6873

Print

Biological Description

Specificity COBRA1 (D6K9A) Rabbit mAb detects endogenous levels of total COBRA1 protein.
Background COBRA1 (NELF-B), a core subunit of the Negative Elongation Factor (NELF) complex alongside WHSC2 (NELF-A), TH1L (NELF-C/D), and NELF-E, is a critical regulator of RNA polymerase II (RNAPII) transcription elongation, promoting promoter-proximal pausing in concert with DSIF and awaiting P-TEFb-mediated release through phosphorylation of both NELF and the RNAPII CTD for productive elongation. COBRA1 is predicted to adopt a HEAT repeat fold, mediating essential intersubunit interactions that anchor NELF-A and RNA-binding NELF-E, thereby stabilizing the NELF complex and facilitating its association with paused RNAPII approximately 20–60 bp downstream of promoters. COBRA1’s principal functions include maintaining RNAPII pausing to allow rapid, signal-dependent gene induction, particularly at developmental and stress-responsive genes, modulating nuclear receptor activity (estrogen, androgen, glucocorticoid receptors) to control target gene expression and alternative splicing, and negatively regulating AP-1 at promoters such as TFF1; notably, it was initially identified through its BRCT-domain interaction with the BRCA1 tumor suppressor. COBRA1 fine-tunes transcriptional output for energy metabolism genes in cardiomyocytes, governs stem cell differentiation, and modulates hormone-driven proliferation. Clinically, reduced COBRA1 expression correlates with poor prognosis in metastatic or recurrent breast cancer, whereas its overexpression promotes androgen receptor signaling and tumor growth/migration in prostate and hepatocellular cancers.

Usage Information

Application WB, IP, ChIP Dilution
WB IP CHIP
1:1000 1:50 1:50
Reactivity Human, Mouse, Rat, Monkey
Source Rabbit Monoclonal Antibody MW 65 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

References

  • https://pubmed.ncbi.nlm.nih.gov/28112367/
  • https://pubmed.ncbi.nlm.nih.gov/37591184/

Application Data